ProShare Advisors’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-11,778	Closed	-$209K	–	2326
2021 Q4	$209K	Buy	+11,778	New	+$209K	﹤0.01%	2005